Terms: = Pancreatic cancer AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1 AND Treatment
84 results:
1. Autoimmune pancreatitis: Cornerstones and future perspectives.
Gallo C; Dispinzieri G; Zucchini N; Invernizzi P; Massironi S
World J Gastroenterol; 2024 Feb; 30(8):817-832. PubMed ID: 38516247
[TBL] [Abstract] [Full Text] [Related]
2. Multiregion WES of metastatic pancreatic neuroendocrine tumors revealed heterogeneity in genomic alterations, immune microenvironment and evolutionary patterns.
Jiang Y; Dong YH; Zhao SW; Liu DY; Zhang JY; Xu XY; Chen H; Chen H; Jin JB
Cell Commun Signal; 2024 Mar; 22(1):164. PubMed ID: 38448900
[TBL] [Abstract] [Full Text] [Related]
3. CircNUP54 promotes hepatocellular carcinoma progression via facilitating HuR cytoplasmic export and stabilizing birc3 mRNA.
Tang C; Zhuang H; Wang W; Wang Q; Ma X; Wang B; Zhang Z; Jiang J; Xie Z; Tan W; Yang L; Liu S; Hua Y; Xiao Y; Ding B; Chen Y; Shang C
Cell Death Dis; 2024 Mar; 15(3):191. PubMed ID: 38443362
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic value of CT-based radiomics in grade 1-2 pancreatic neuroendocrine tumors.
Heo S; Park HJ; Kim HJ; Kim JH; Park SY; Kim KW; Kim SY; Choi SH; Byun JH; Kim SC; Hwang HS; Hong SM
Cancer Imaging; 2024 Feb; 24(1):28. PubMed ID: 38395973
[TBL] [Abstract] [Full Text] [Related]
5. Observational study of surgical resection in small non-functional pancreatic neuroendocrine tumors: AS SEER-based study.
Lin J; Huang H
Sci Rep; 2023 Aug; 13(1):12824. PubMed ID: 37550460
[TBL] [Abstract] [Full Text] [Related]
6. Multi-omics analysis reveals the chemoresistance mechanism of proliferating tissue-resident macrophages in PDAC via metabolic adaptation.
Zhang J; Song J; Tang S; Zhao Y; Wang L; Luo Y; Tang J; Ji Y; Wang X; Li T; Zhang H; Shao W; Sheng J; Liang T; Bai X
Cell Rep; 2023 Jun; 42(6):112620. PubMed ID: 37285267
[TBL] [Abstract] [Full Text] [Related]
7. Intratumoral injection therapies for locally advanced pancreatic cancer: systematic review.
Willink CY; Jenniskens SFM; Klaassen NJM; Stommel MWJ; Nijsen JFW
BJS Open; 2023 May; 7(3):. PubMed ID: 37254902
[TBL] [Abstract] [Full Text] [Related]
8. The predictive value of PD-L1 expression in patients with advanced hepatocellular carcinoma treated with PD-1/PD-L1 inhibitors: A systematic review and meta-analysis.
Yang Y; Chen D; Zhao B; Ren L; Huang R; Feng B; Chen H
Cancer Med; 2023 Apr; 12(8):9282-9292. PubMed ID: 36965092
[TBL] [Abstract] [Full Text] [Related]
9. Hospital Designations and Their Impact on Guideline-Concordant Care and Survival in pancreatic cancer. Do They Matter?
Murimwa GZ; Karalis JD; Meier J; Yan J; Zhu H; Hester CA; Porembka MR; Wang SC; Mansour JC; Zeh HJ; Yopp AC; Polanco PM
Ann Surg Oncol; 2023 Jul; 30(7):4377-4387. PubMed ID: 36964844
[TBL] [Abstract] [Full Text] [Related]
10. Robotic Right Posterior Sectionectomy by Intrafascial Approach for Pancreas Neuroendocrine Liver Metastasis.
Saadoun JE; Vanbrugghe C; Fara R; Camerlo A
Ann Surg Oncol; 2023 Jul; 30(7):4276. PubMed ID: 36949294
[TBL] [Abstract] [Full Text] [Related]
11. Anticancer Benefit of Metformin in Patients With Early-Stage pancreatic cancer: A Retrospective Cohort Study.
Chen Y; Qian FJ; Ye ZQ; Xie WX; He YD; Huang JR; Tian L; Gu DN
Technol Cancer Res Treat; 2022; 21():15330338221138208. PubMed ID: 36583563
[No Abstract] [Full Text] [Related]
12. Systemic Chemotherapy With or Without Hepatic Arterial Infusion Chemotherapy for Liver Metastases From pancreatic cancer: A Propensity Score Matching Analysis.
Ouyang H; Ma W; Si T; Liu D; Chen P; Gerdtsson AS; Song J; Ni Y; Luo J; Yan Z
Clin Colorectal Cancer; 2023 Mar; 22(1):111-119. PubMed ID: 36473779
[TBL] [Abstract] [Full Text] [Related]
13. Efficacy and safety of self-expandable metal stent placement for treatment of primary and metastatic gastric outlet obstruction.
Lai H; Wu K; Liu Y; Li D; Peng T; Zhang B
Ir J Med Sci; 2023 Oct; 192(5):2077-2084. PubMed ID: 36441448
[TBL] [Abstract] [Full Text] [Related]
14. FL118, acting as a 'molecular glue degrader', binds to dephosphorylates and degrades the oncoprotein DDX5 (p68) to control c-Myc, survivin and mutant Kras against colorectal and pancreatic cancer with high efficacy.
Ling X; Wu W; Aljahdali IAM; Liao J; Santha S; Fountzilas C; Boland PM; Li F
Clin Transl Med; 2022 May; 12(5):e881. PubMed ID: 35604033
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic values of B7-H3, B7-H4, and HHLA2 expression in human pancreatic cancer tissues based on mihc and spatial distribution analysis.
Zhu Y; Chen J; Liu Y; Zheng X; Feng J; Chen X; Jiang T; Li Y; Chen L
Pathol Res Pract; 2022 Jun; 234():153911. PubMed ID: 35489125
[TBL] [Abstract] [Full Text] [Related]
16. Laparoscopic Enucleation of pancreatic Neoplasms: A Single-Center Experience and Outcomes.
Bruballa R; Fratantoni ME; Ardiles V; Mazza O
J Laparoendosc Adv Surg Tech A; 2022 Oct; 32(10):1032-1037. PubMed ID: 35446126
[No Abstract] [Full Text] [Related]
17. Association of Adjuvant Chemotherapy With Overall Survival Among Patients With Locally Advanced Gastric cancer After Neoadjuvant Chemotherapy.
Lin JX; Tang YH; Lin GJ; Ma YB; Desiderio J; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Zheng CH; Parisi A; Truty MJ; Huang CM
JAMA Netw Open; 2022 Apr; 5(4):e225557. PubMed ID: 35363268
[TBL] [Abstract] [Full Text] [Related]
18. Dysregulated expression and functions of microRNA-330 in cancers: A potential therapeutic target.
Jafarzadeh A; Paknahad MH; Nemati M; Jafarzadeh S; Mahjoubin-Tehran M; Rajabi A; Shojaie L; Mirzaei H
Biomed Pharmacother; 2022 Feb; 146():112600. PubMed ID: 34968919
[TBL] [Abstract] [Full Text] [Related]
19. Modulation of the Human pancreatic Ductal Adenocarcinoma Immune Microenvironment by Stereotactic Body Radiotherapy.
Mills BN; Qiu H; Drage MG; Chen C; Mathew JS; Garrett-Larsen J; Ye J; Uccello TP; Murphy JD; Belt BA; Lord EM; Katz AW; Linehan DC; Gerber SA
Clin Cancer Res; 2022 Jan; 28(1):150-162. PubMed ID: 34862242
[TBL] [Abstract] [Full Text] [Related]
20. Identification and Validation of Immune Molecular Subtypes in pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy.
Li R; He Y; Zhang H; Wang J; Liu X; Liu H; Wu H; Liang Z
Front Immunol; 2021; 12():690056. PubMed ID: 34335594
[TBL] [Abstract] [Full Text] [Related]
[Next]
